Catalog name Description price
R-C-3090 Tyrphostin 9 CAS:10537-47-0 Tyrphostin 9 (SF 6847, RG-50872) is firstly designed as an EGFR inhibitor with IC50 of 460 μM, but is also found to be more potent to PDGFR with IC50 of 0.5 μM.Only for scientific research, not for human body. price>
R-C-3091 TAK-593 CAS:1005780-62-0 TAK-593 is an oral formulation containing a small-molecule receptor tyrosine kinase inhibitor of both vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity.Only for scientific research, not for human body. price>
R-C-3092 SU5402 CAS:215543-92-3 SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, 30 nM, and 510 nM for VEGFR2, FGFR1, and PDGF-Rβ, respectively.Only for scientific research, not for human body. price>
R-C-3093 SAR131675 CAS:1433953-83-3 SAR131675, a potent and selective VEGFR-3-TK inhibitor with antilymphangiogenic, antitumoral, and antimetastatic activities.Only for scientific research, not for human body. price>
R-C-3094 SU 5416 (Semaxinib) CAS: 204005-46-9 SU 5416 is an inhibitor of vascular endothelial growth factor receptor (VEGFR) that also inhibits other tyrosine kinases KIT, MET, FLT3 and RET.Only for scientific research, not for human body. price>
R-C-3095 CP-547632 CAS:252003-65-9 CP-547632 is a novel, potent vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor.Only for scientific research, not for human body. price>
R-C-3096 CP-673451 CAS:343787-29-1 CP-673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM in cell-free assays, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.Only for scientific research, not for human body. price>